{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:00:48Z","timestamp":1779163248383,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11239-021-02585-2","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T21:46:57Z","timestamp":1634766417000},"page":"739-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of colchicine on tissue factor in oxLDL-activated T-lymphocytes"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7818-4952","authenticated-orcid":false,"given":"Plinio","family":"Cirillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giusi","family":"Barra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"De Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhmetzhan","family":"Sugraliyev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Golino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Cimmino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"2585_CR1","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Boren","year":"2020","unstructured":"Boren J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ et al (2020) Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 41:2313\u20132330. https:\/\/doi.org\/10.1093\/eurheartj\/ehz962","journal-title":"Eur Heart J"},{"key":"2585_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2016.05.013","volume":"84","author":"N Di Pietro","year":"2016","unstructured":"Di Pietro N, Formoso G, Pandolfi A (2016) Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis. Vasc Pharmacol 84:1\u20137. https:\/\/doi.org\/10.1016\/j.vph.2016.05.013","journal-title":"Vasc Pharmacol"},{"key":"2585_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/01.ATV.0000253884.13901.e4","volume":"27","author":"M Simionescu","year":"2007","unstructured":"Simionescu M (2007) Implications of early structural\u2013functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol 27:266\u2013274. https:\/\/doi.org\/10.1161\/01.ATV.0000253884.13901.e4","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2585_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1573403X12666161014093812","volume":"13","author":"G Cimmino","year":"2017","unstructured":"Cimmino G, Loffredo FS, Morello A, D\u2019Elia S, De Palma R, Cirillo P, Golino P (2017) Immune-inflammatory activation in acute coronary syndromes: a look into the heart of unstable coronary plaque. Curr Cardiol Rev 13:110\u2013117. https:\/\/doi.org\/10.2174\/1573403X12666161014093812","journal-title":"Curr Cardiol Rev"},{"key":"2585_CR5","first-page":"349","volume":"54","author":"E Profumo","year":"2013","unstructured":"Profumo E, Buttari B, Tosti ME, Tagliani A, Capoano R, D\u2019Amati G, Businaro R, Salvati B, Rigano R (2013) Plaque-infiltrating T lymphocytes in patients with carotid atherosclerosis: an insight into the cellular mechanisms associated to plaque destabilization. J Cardiovasc Surg 54:349\u2013357","journal-title":"J Cardiovasc Surg"},{"key":"2585_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/571846","volume":"2012","author":"S Samson","year":"2012","unstructured":"Samson S, Mundkur L, Kakkar VV (2012) Immune response to lipoproteins in atherosclerosis. Cholesterol 2012:571846. https:\/\/doi.org\/10.1155\/2012\/571846","journal-title":"Cholesterol"},{"key":"2585_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nri1882","volume":"6","author":"GK Hansson","year":"2006","unstructured":"Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6:508\u2013519. https:\/\/doi.org\/10.1038\/nri1882","journal-title":"Nat Rev Immunol"},{"key":"2585_CR8","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1161\/CIRCULATIONAHA.105.537712","volume":"113","author":"R De Palma","year":"2006","unstructured":"De Palma R, Del Galdo F, Abbate G, Chiariello M, Calabro R, Forte L, Cimmino G, Papa MF, Russo MG, Ambrosio G et al (2006) Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. Circulation 113:640\u2013646. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.537712","journal-title":"Circulation"},{"key":"2585_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijcard.2016.04.177","volume":"218","author":"R De Palma","year":"2016","unstructured":"De Palma R, Cirillo P, Ciccarelli G, Barra G, Conte S, Pellegrino G, Pasquale G, Nassa G, Pacifico F, Leonardi A et al (2016) Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: a possible contribution of immunity to thrombosis? Int J Cardiol 218:188\u2013195. https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.177","journal-title":"Int J Cardiol"},{"key":"2585_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","volume":"120","author":"A Oesterle","year":"2017","unstructured":"Oesterle A, Laufs U, Liao JK (2017) Pleiotropic effects of statins on the cardiovascular system. Circ Res 120:229\u2013243. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308537","journal-title":"Circ Res"},{"key":"2585_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab032","author":"D Yu","year":"2021","unstructured":"Yu D, Liao JK (2021) Emerging views of statin pleiotropy and cholesterol lowering. Cardiovasc Res. https:\/\/doi.org\/10.1093\/cvr\/cvab032","journal-title":"Cardiovasc Res"},{"key":"2585_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.5414\/cpp41397","volume":"41","author":"A Hilgendorff","year":"2003","unstructured":"Hilgendorff A, Muth H, Parviz B, Staubitz A, Haberbosch W, Tillmanns H, Holschermann H (2003) Statins differ in their ability to block NF-kappaB activation in human blood monocytes. Int J Clin Pharmacol Ther 41:397\u2013401. https:\/\/doi.org\/10.5414\/cpp41397","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2585_CR13","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1111\/j.1538-7836.2011.04366.x","volume":"9","author":"C Banfi","year":"2011","unstructured":"Banfi C, Brioschi M, Lento S, Pirillo A, Galli S, Cosentino S, Tremoli E, Mussoni L (2011) Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro. J Thromb Haemost 9:1608\u20131619. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04366.x","journal-title":"J Thromb Haemost"},{"key":"2585_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.atherosclerosis.2016.12.019","volume":"257","author":"O Panes","year":"2017","unstructured":"Panes O, Gonzalez C, Hidalgo P, Valderas JP, Acevedo M, Contreras S, Sanchez X, Pereira J, Rigotti A, Mezzano D (2017) Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin, but not by atorvastatin. Atherosclerosis 257:164\u2013171. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.12.019","journal-title":"Atherosclerosis"},{"key":"2585_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","volume":"162","author":"PM Ridker","year":"2011","unstructured":"Ridker PM, Thuren T, Zalewski A, Libby P (2011) Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am Heart J 162:597\u2013605. https:\/\/doi.org\/10.1016\/j.ahj.2011.06.012","journal-title":"Am Heart J"},{"key":"2585_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ahj.2013.03.018","volume":"166","author":"BM Everett","year":"2013","unstructured":"Everett BM, Pradhan AD, Solomon DH, Paynter N, Macfadyen J, Zaharris E, Gupta M, Clearfield M, Libby P, Hasan AA et al (2013) Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. Am Heart J 166:199\u2013207. https:\/\/doi.org\/10.1016\/j.ahj.2013.03.018","journal-title":"Am Heart J"},{"key":"2585_CR17","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu XF, Ireland MA, Lenderink T et al (2020) Colchicine in patients with chronic coronary disease. N Engl J Med 383:1838\u20131847. https:\/\/doi.org\/10.1056\/NEJMoa2021372","journal-title":"N Engl J Med"},{"key":"2585_CR18","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS et al (2019) Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 381:2497\u20132505. https:\/\/doi.org\/10.1056\/NEJMoa1912388","journal-title":"N Engl J Med"},{"key":"2585_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","volume":"61","author":"SM Nidorf","year":"2013","unstructured":"Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL (2013) Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol 61:404\u2013410. https:\/\/doi.org\/10.1016\/j.jacc.2012.10.027","journal-title":"J Am Coll Cardiol"},{"key":"2585_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.vph.2018.09.004","volume":"111","author":"G Cimmino","year":"2018","unstructured":"Cimmino G, Tarallo R, Conte S, Morello A, Pellegrino G, Loffredo FS, Cali G, De Luca N, Golino P, Trimarco B et al (2018) Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1. Vascul Pharmacol 111:62\u201370. https:\/\/doi.org\/10.1016\/j.vph.2018.09.004","journal-title":"Vascul Pharmacol"},{"key":"2585_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s11239-020-02121-8","volume":"50","author":"P Cirillo","year":"2020","unstructured":"Cirillo P, Taglialatela V, Pellegrino G, Morello A, Conte S, Di Serafino L, Cimmino G (2020) Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel. J Thromb Thrombol 50:468\u2013472. https:\/\/doi.org\/10.1007\/s11239-020-02121-8","journal-title":"J Thromb Thrombol"},{"key":"2585_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2020.106822","volume":"137","author":"G Cimmino","year":"2021","unstructured":"Cimmino G, Conte S, Morello A, Pellegrino G, Marra L, Cali G, Golino P, Cirillo P (2021) Colchicine inhibits the prothrombotic effects of oxLDL in human endothelial cells. Vasc Pharmacol 137:106822. https:\/\/doi.org\/10.1016\/j.vph.2020.106822","journal-title":"Vasc Pharmacol"},{"key":"2585_CR23","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1111\/j.1582-4934.2008.00614.x","volume":"13","author":"G Cimmino","year":"2009","unstructured":"Cimmino G, Ibanez B, Vilahur G, Speidl WS, Fuster V, Badimon L, Badimon JJ (2009) Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano). J Cell Mol Med 13:3226\u20133235. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00614.x","journal-title":"J Cell Mol Med"},{"key":"2585_CR24","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1093\/cvr\/cvz230","volume":"116","author":"G Cimmino","year":"2020","unstructured":"Cimmino G, Cirillo P, Conte S, Pellegrino G, Barra G, Maresca L, Morello A, Cali G, Loffredo F, De Palma R et al (2020) Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1. Cardiovasc Res 116:1125\u20131135. https:\/\/doi.org\/10.1093\/cvr\/cvz230","journal-title":"Cardiovasc Res"},{"key":"2585_CR25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/clinchem\/hvaa125","volume":"66","author":"JF Huggett","year":"2020","unstructured":"Huggett JF (2020) The digital MIQE guidelines update: minimum information for publication of quantitative digital PCR experiments for 2020. Clin Chem 66:1012\u20131029. https:\/\/doi.org\/10.1093\/clinchem\/hvaa125","journal-title":"Clin Chem"},{"key":"2585_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/01.atv.17.2.365","volume":"17","author":"P Oeth","year":"1997","unstructured":"Oeth P, Parry GC, Mackman N (1997) Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B\/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol 17:365\u2013374. https:\/\/doi.org\/10.1161\/01.atv.17.2.365","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2585_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bcp.2016.12.016","volume":"128","author":"P Cirillo","year":"2017","unstructured":"Cirillo P, Conte S, Cimmino G, Pellegrino G, Ziviello F, Barra G, Sasso FC, Borgia F, De Palma R, Trimarco B (2017) Nobiletin inhibits oxidized-LDL mediated expression of tissue factor in human endothelial cells through inhibition of NF-kappaB. Biochem Pharmacol 128:26\u201333. https:\/\/doi.org\/10.1016\/j.bcp.2016.12.016","journal-title":"Biochem Pharmacol"},{"key":"2585_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","volume":"124","author":"D Wolf","year":"2019","unstructured":"Wolf D, Ley K (2019) Immunity and inflammation in atherosclerosis. Circ Res 124:315\u2013327. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313591","journal-title":"Circ Res"},{"key":"2585_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/MOL.0000000000000539","volume":"29","author":"NP Riksen","year":"2018","unstructured":"Riksen NP, Stienstra R (2018) Metabolism of innate immune cells: impact on atherosclerosis. Curr Opin Lipidol 29:359\u2013367. https:\/\/doi.org\/10.1097\/MOL.0000000000000539","journal-title":"Curr Opin Lipidol"},{"key":"2585_CR30","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.imbio.2016.05.010","volume":"221","author":"DA Chistiakov","year":"2016","unstructured":"Chistiakov DA, Orekhov AN, Bobryshev YV (2016) Immune-inflammatory responses in atherosclerosis: role of an adaptive immunity mainly driven by T and B cells. Immunobiology 221:1014\u20131033. https:\/\/doi.org\/10.1016\/j.imbio.2016.05.010","journal-title":"Immunobiology"},{"key":"2585_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/MOL.0000000000000302","volume":"27","author":"F Schaftenaar","year":"2016","unstructured":"Schaftenaar F, Frodermann V, Kuiper J, Lutgens E (2016) Atherosclerosis: the interplay between lipids and immune cells. Curr Opin Lipidol 27:209\u2013215. https:\/\/doi.org\/10.1097\/MOL.0000000000000302","journal-title":"Curr Opin Lipidol"},{"key":"2585_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijcard.2014.05.035","volume":"176","author":"P Cirillo","year":"2014","unstructured":"Cirillo P, Cimmino G, D\u2019Aiuto E, Di Palma V, Abbate G, Piscione F, Golino P, De Palma R (2014) Local cytokine production in patients with acute coronary syndromes: a look into the eye of the perfect (cytokine) storm. Int J Cardiol 176:227\u2013229. https:\/\/doi.org\/10.1016\/j.ijcard.2014.05.035","journal-title":"Int J Cardiol"},{"key":"2585_CR33","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1161\/CIRCRESAHA.108.182428","volume":"103","author":"I Gotsman","year":"2008","unstructured":"Gotsman I, Sharpe AH, Lichtman AH (2008) T-cell costimulation and coinhibition in atherosclerosis. Circ Res 103:1220\u20131231. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.182428","journal-title":"Circ Res"},{"key":"2585_CR34","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1161\/01.cir.101.25.2883","volume":"101","author":"G Liuzzo","year":"2000","unstructured":"Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, Weyand CM (2000) Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 101:2883\u20132888. https:\/\/doi.org\/10.1161\/01.cir.101.25.2883","journal-title":"Circulation"},{"key":"2585_CR35","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s11883-008-0037-8","volume":"10","author":"P Aukrust","year":"2008","unstructured":"Aukrust P, Otterdal K, Yndestad A, Sandberg WJ, Smith C, Ueland T, Oie E, Damas JK, Gullestad L, Halvorsen B (2008) The complex role of T-cell-based immunity in atherosclerosis. Curr Atheroscler Rep 10:236\u2013243. https:\/\/doi.org\/10.1007\/s11883-008-0037-8","journal-title":"Curr Atheroscler Rep"},{"key":"2585_CR36","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1073\/pnas.92.9.3893","volume":"92","author":"S Stemme","year":"1995","unstructured":"Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK (1995) T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 92:3893\u20133897. https:\/\/doi.org\/10.1073\/pnas.92.9.3893","journal-title":"Proc Natl Acad Sci USA"},{"key":"2585_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11883-014-0401-9","volume":"16","author":"CG Santos-Gallego","year":"2014","unstructured":"Santos-Gallego CG, Picatoste B, Badimon JJ (2014) Pathophysiology of acute coronary syndrome. Curr Atheroscler Rep 16:401. https:\/\/doi.org\/10.1007\/s11883-014-0401-9","journal-title":"Curr Atheroscler Rep"},{"key":"2585_CR38","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"PS Sever","year":"2003","unstructured":"Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT et al (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361:1149\u20131158. https:\/\/doi.org\/10.1016\/S0140-6736(03)12948-0","journal-title":"Lancet"},{"key":"2585_CR39","first-page":"1383","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","unstructured":"Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383\u20131389","journal-title":"Lancet"},{"key":"2585_CR40","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","volume":"285","author":"GG Schwartz","year":"2001","unstructured":"Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T et al (2001) Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285:1711\u20131718. https:\/\/doi.org\/10.1001\/jama.285.13.1711","journal-title":"JAMA"},{"key":"2585_CR41","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","volume":"287","author":"PW Serruys","year":"2002","unstructured":"Serruys PW, de Feyter P, Macaya C, Kokott N, Puel J, Vrolix M, Branzi A, Bertolami MC, Jackson G, Strauss B et al (2002) Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA 287:3215\u20133222. https:\/\/doi.org\/10.1001\/jama.287.24.3215","journal-title":"JAMA"},{"key":"2585_CR42","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195\u20132207. https:\/\/doi.org\/10.1056\/NEJMoa0807646","journal-title":"N Engl J Med"},{"key":"2585_CR43","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131530","author":"PW Karmaus","year":"2019","unstructured":"Karmaus PW, Shi M, Perl S, Biancotto A, Candia J, Cheung F, Kotliarov Y, Young N, Fessler MB (2019) Effects of rosuvastatin on the immune system in healthy volunteers with normal serum cholesterol. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.131530","journal-title":"JCI Insight"},{"key":"2585_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20143534","author":"LW Chen","year":"2019","unstructured":"Chen LW, Lin CS, Tsai MC, Shih SF, Lim ZW, Chen SJ, Tsui PF, Ho LJ, Lai JH, Liou JT (2019) Pitavastatin exerts potent anti-inflammatory and immunomodulatory effects via the suppression of AP-1 signal transduction in human T cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20143534","journal-title":"Int J Mol Sci"},{"key":"2585_CR45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","volume":"128","author":"A Slobodnick","year":"2015","unstructured":"Slobodnick A, Shah B, Pillinger MH, Krasnokutsky S (2015) Colchicine: old and new. Am J Med 128:461\u2013470. https:\/\/doi.org\/10.1016\/j.amjmed.2014.12.010","journal-title":"Am J Med"},{"key":"2585_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","volume":"45","author":"YY Leung","year":"2015","unstructured":"Leung YY, Yao Hui LL, Kraus VB (2015) Colchicine-update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum 45:341\u2013350. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.013","journal-title":"Semin Arthritis Rheum"},{"key":"2585_CR47","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Y Adler","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, Badano L, Baron-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C et al (2015) 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 36:2921\u20132964. https:\/\/doi.org\/10.1093\/eurheartj\/ehv318","journal-title":"Eur Heart J"},{"key":"2585_CR48","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002128","volume":"4","author":"GJ Martinez","year":"2015","unstructured":"Martinez GJ, Robertson S, Barraclough J, Xia Q, Mallat Z, Bursill C, Celermajer DS, Patel S (2015) Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome. J Am Heart Assoc 4:e002128. https:\/\/doi.org\/10.1161\/JAHA.115.002128","journal-title":"J Am Heart Assoc"},{"key":"2585_CR49","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tibs.2003.12.003","volume":"29","author":"Y Yamamoto","year":"2004","unstructured":"Yamamoto Y, Gaynor RB (2004) IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci 29:72\u201379. https:\/\/doi.org\/10.1016\/j.tibs.2003.12.003","journal-title":"Trends Biochem Sci"},{"key":"2585_CR50","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1055\/s-0038-1657623","volume":"78","author":"N Mackman","year":"1997","unstructured":"Mackman N (1997) Regulation of the tissue factor gene. Thromb Haemost 78:747\u2013754","journal-title":"Thromb Haemost"},{"key":"2585_CR51","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/01.ATV.0000160340.72641.87","volume":"25","author":"MP de Winther","year":"2005","unstructured":"de Winther MP, Kanters E, Kraal G, Hofker MH (2005) Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25:904\u2013914. https:\/\/doi.org\/10.1161\/01.ATV.0000160340.72641.87","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2585_CR52","first-page":"341","volume":"42","author":"BB Aggarwal","year":"2004","unstructured":"Aggarwal BB, Takada Y, Shishodia S, Gutierrez AM, Oommen OV, Ichikawa H, Baba Y, Kumar A (2004) Nuclear transcription factor NF-kappa B: role in biology and medicine. Indian J Exp Biol 42:341\u2013353","journal-title":"Indian J Exp Biol"},{"key":"2585_CR53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11010-013-1751-2","volume":"383","author":"Y Cao","year":"2013","unstructured":"Cao Y, Zhou X, Liu H, Zhang Y, Yu X, Liu C (2013) The NF-kappaB pathway: regulation of the instability of atherosclerotic plaques activated by Fg, Fb, and FDPs. Mol Cell Biochem 383:29\u201337. https:\/\/doi.org\/10.1007\/s11010-013-1751-2","journal-title":"Mol Cell Biochem"},{"key":"2585_CR54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jacc.2006.07.071","volume":"49","author":"G Liuzzo","year":"2007","unstructured":"Liuzzo G, Santamaria M, Biasucci LM, Narducci M, Colafrancesco V, Porto A, Brugaletta S, Pinnelli M, Rizzello V, Maseri A et al (2007) Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. J Am Coll Cardiol 49:185\u2013194. https:\/\/doi.org\/10.1016\/j.jacc.2006.07.071","journal-title":"J Am Coll Cardiol"},{"key":"2585_CR55","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0021-9150(01)00546-9","volume":"160","author":"SH Wilson","year":"2002","unstructured":"Wilson SH, Best PJ, Edwards WD, Holmes DR Jr, Carlson PJ, Celermajer DS, Lerman A (2002) Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis 160:147\u2013153. https:\/\/doi.org\/10.1016\/s0021-9150(01)00546-9","journal-title":"Atherosclerosis"},{"key":"2585_CR56","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1161\/01.cir.98.17.1707","volume":"98","author":"ME Ritchie","year":"1998","unstructured":"Ritchie ME (1998) Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris. Circulation 98:1707\u20131713. https:\/\/doi.org\/10.1161\/01.cir.98.17.1707","journal-title":"Circulation"},{"key":"2585_CR57","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1160\/TH14-05-0451","volume":"113","author":"P Cirillo","year":"2015","unstructured":"Cirillo P, Ziviello F, Pellegrino G, Conte S, Cimmino G, Giaquinto A, Pacifico F, Leonardi A, Golino P, Trimarco B (2015) The adipokine apelin-13 induces expression of prothrombotic tissue factor. Thromb Haemost 113:363\u2013372. https:\/\/doi.org\/10.1160\/TH14-05-0451","journal-title":"Thromb Haemost"},{"key":"2585_CR58","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.thromres.2012.06.007","volume":"130","author":"P Cirillo","year":"2012","unstructured":"Cirillo P, Di Palma V, Maresca F, Pacifico F, Ziviello F, Bevilacqua M, Trimarco B, Leonardi A, Chiariello M (2012) The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells: another piece in the adipokines puzzle. Thromb Res 130:403\u2013408. https:\/\/doi.org\/10.1016\/j.thromres.2012.06.007","journal-title":"Thromb Res"},{"key":"2585_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000318775","volume":"48","author":"P Calabro","year":"2011","unstructured":"Calabro P, Cirillo P, Limongelli G, Maddaloni V, Riegler L, Palmieri R, Pacileo G, De Rosa S, Pacileo M, De Palma R et al (2011) Tissue factor is induced by resistin in human coronary artery endothelial cells by the NF-kB-dependent pathway. J Vasc Res 48:59\u201366. https:\/\/doi.org\/10.1159\/000318775","journal-title":"J Vasc Res"},{"key":"2585_CR60","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1161\/01.atv.0000043456.48735.20","volume":"23","author":"W Dichtl","year":"2003","unstructured":"Dichtl W, Dulak J, Frick M, Alber HF, Schwarzacher SP, Ares MP, Nilsson J, Pachinger O, Weidinger F (2003) HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23:58\u201363. https:\/\/doi.org\/10.1161\/01.atv.0000043456.48735.20","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02585-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-021-02585-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02585-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T08:13:46Z","timestamp":1649405626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-021-02585-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2585"],"URL":"https:\/\/doi.org\/10.1007\/s11239-021-02585-2","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"assertion":[{"value":"30 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors has had a relationship with the industry within the past 2\u00a0years that might pose a conflict of interest in connection with this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}